동아ST

We will continue to strive for global new drug development.

NEWS

No Subject Date View
6

Dong-A ST to develop AAV gene therapy in collaboration with UMass Chan

2023-12-19 1132
5

Dong-A ST Gears Up for Global Growth at CPHI Worldwide 2023 in Barcelona

2023-12-19 1886
4

Dong-A ST Unveils Cutting-Edge Immuno-Oncology Drug Candidate 'DA-4511' at AACR-NCI-EORTC 2023

2023-12-19 1145
3

HK inno.N set to develop 5th-generation lung cancer drug

2023-12-19 2130
2

Dong-A ST eyes Europe market with Stelara biosimilar

2023-12-18 1131
1

Dong-A ST Announces Promising Results of Immune Oncology Candidate DA-4505 at AACR 2023

2023-09-22 1541